Clinical trial
Evidence - Evaluation of Potential Predictors of Disease Progression in Patients With aHUS, Including Genetics, Biomarkers and Treatment
NCT02614898 is registered in ClinicalTrials.gov with Alexion Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evidence - Evaluation of Potential Predictors of Disease Progression in Patients With aHUS, Including Genetics, Biomarkers and Treatment
- Lead sponsor
- Alexion Pharmaceuticals, Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- November 4, 2015
- Completion date
- October 5, 2017
- Enrollment
- 67 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.